
Abstract CT137: A pilot pharmacokinetic study of VAL413 in patients with recurrent pediatric solid tumors
Author(s) -
James I. Geller,
Dennis Brown,
Jeffrey Bacha,
Neil Sankar,
Sarath Kanekal,
Mark Leggas,
Lars M. Wagner
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct137
Subject(s) - medicine , irinotecan , tolerability , temozolomide , rhabdomyosarcoma , pharmacokinetics , pediatric cancer , oncology , cancer , sarcoma , colorectal cancer , chemotherapy , adverse effect , pathology